Literature DB >> 466861

The quantification of viable Leishmania enriettii from infected guinea-pig tissues.

L W Poulter.   

Abstract

Results are presented demonstrating that in vitro cultivation of Leishmania enrietti can be used to determine the level of viability in suspensions of L. enrietti used for infection and also to quantify the number of viable organisms in infected tissues.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 466861      PMCID: PMC1537695     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  12 in total

1.  Mechanisms of protective immunity in experimental cutaneous leishmaniasis of the guinea-pig. III. Inhibition of leishmanial lesion in the guinea-pig by delayed hypersensitivity reaction to unrelated antigens.

Authors:  R Behin; J Mauel; D S Rowe
Journal:  Clin Exp Immunol       Date:  1977-08       Impact factor: 4.330

2.  Modification of cutaneous leishmaniasis in the guinea-pig by cyclophosphamide.

Authors:  A Belehu; L W Poulter; J L Turk
Journal:  Clin Exp Immunol       Date:  1976-04       Impact factor: 4.330

3.  Infectivity of Leishmania donovani amastigotes and promastigotes for golden hamsters.

Authors:  J S Keithly
Journal:  J Protozool       Date:  1976-05

4.  The kinetics and quality of acquired resistance in self-healing and metastatic leishmaniasis.

Authors:  L W Poulter
Journal:  Clin Exp Immunol       Date:  1979-04       Impact factor: 4.330

5.  Experimental cutaneous leishmaniasis. IV. Selective suppression of cell-mediated immunity during the response of guinea-pigs to infection with Leishmania enriettii.

Authors:  A D Bryceson; R S Bray; D C Dumonde
Journal:  Clin Exp Immunol       Date:  1974-02       Impact factor: 4.330

6.  The effect of prolonged treatment with antilymphocyte serum on the course of infections with BCG and Leishmania enriettii in the guinea-pig.

Authors:  A D Bryceson; J L Turk
Journal:  J Pathol       Date:  1971-07       Impact factor: 7.996

7.  Immunity in cutaneous leishmaniasis of the guinea-pig.

Authors:  A D Bryceson; R S Bray; R A Wolstencroft; D C Dumonde
Journal:  Clin Exp Immunol       Date:  1970-09       Impact factor: 4.330

8.  Anti-leishmanial activity of immune guinea-pig serum.

Authors:  H Rezai; S Gettner; N Behforouz
Journal:  J Med Microbiol       Date:  1972-08       Impact factor: 2.472

9.  Experimental cutaneous leishmaniasis. II. Effects of immunosuppression and antigenic competition on the course of infection with Leishmania enriettii in the guinea-pig.

Authors:  A D Bryceson; P M Preston; R S Bray; D C Dumonde
Journal:  Clin Exp Immunol       Date:  1972-02       Impact factor: 4.330

10.  Partial purification of amastigotes from cutaneous lesions of American leishmaniasis.

Authors:  G E Childs; M J McRoberts; K A Foster
Journal:  J Parasitol       Date:  1976-10       Impact factor: 1.276

View more
  6 in total

1.  Protection of guinea pigs against cutaneous leishmaniasis by combined infection and chemotherapy.

Authors:  J El-On; A Witztum; L F Schnur
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

2.  Mechanisms of immunity to leishmaniasis. II. Significance of the intramacrophage localization of the parasite.

Authors:  L W Poulter
Journal:  Clin Exp Immunol       Date:  1980-04       Impact factor: 4.330

3.  Mechanisms of immunity to leishmaniasis III. The development and decay of resistance during metastatic disease.

Authors:  L W Poulter; M T Pearce
Journal:  Clin Exp Immunol       Date:  1980-11       Impact factor: 4.330

4.  Advantages of measuring changes in the number of viable parasites in murine models of experimental cutaneous leishmaniasis.

Authors:  J O Hill; R J North; F M Collins
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

5.  Mechanisms of immunity to leishmaniasis. IV. Significance of lymphatic drainage from the site of infection.

Authors:  L W Poulter; C R Pandolph
Journal:  Clin Exp Immunol       Date:  1982-05       Impact factor: 4.330

6.  Mechanisms of immunity to leishmaniasis. I. Evidence for a changing basis of protection in self-limiting disease.

Authors:  L W Poulter
Journal:  Clin Exp Immunol       Date:  1980-01       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.